Psychedelics ATMA CENA opens Alberta psychedelic therapy clinics, Ontario locations to follow The treatment provider is a joint venture between ATMA Journey Centers and Cena Life Rowan DunneMarch 14, 2024
Psychedelics Afghanistan Veteran gets Health Canada approval for psilocybin treatment from Apex Labs Kelsi Sheren said that other treatment methods for her PTSD and depression were ineffective Rowan DunneSeptember 28, 2023
News Lucy Scientific partners with TheraPsil to facilitate patient access to psilocybin The partnership also enables Lucy to introduce natural psilocybin products into the Canadian market Natalia Buendia CalvilloMay 18, 2023
Psychedelics PharmAla Biotech first to get Special Access Program authorization for its MDMA Health Canada granted PharmAla approval to provide its LaNeo product to a physician that will facilitate MDMA-assisted therapy Rowan DunneMay 16, 2023
Psychedelics Psilocybin access denied to patients despite ongoing lawsuit against Health Canada Eight patients sued the government at the end of July last year over what they believe is a violation of constitutional rights Rowan DunneMarch 24, 2023
Psychedelics Optimi Health submits clinical trial application after developing proprietary MDMA drug The drug will be used to help establish a safe supply for patients in Canada and Australia Rowan DunneFebruary 7, 2023
Canada Field Trip facilitates beneficial psychedelic-assisted therapy for cancer patient Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada Rowan DunneSeptember 2, 2022
Canada Proposed amendment could greatly expand access to psychedelic therapy in Canada Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program Natalia Buendia CalvilloJanuary 28, 2021